Targeting somatic gene therapy to joints

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 48/00 (2006.01) A01K 67/027 (2006.01) A61K 47/48 (2006.01) C07K 14/705 (2006.01) C07K 14/715 (2006.01) C12N 5/10 (2006.01) C12N 9/06 (2006.01) C12N 9/12 (2006.01) C12N 9/14 (2006.01) C12N 15/11 (2006.01) C12N 15/85 (2006.01) C12N 15/87 (2006.01) C12N 15/88 (2006.01) C12Q 1/02 (2006.01) G01N 33/48 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2139948

A method of transfecting a cell in a structure of a joint is disclosed, wherein a DNA vector containing a nucleic acid cas- sette encoding, for example, a cell ablation agent or a therapeutic agent, is directly injected into the joint. The invention also in- cludes a transfected synovial cell.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Targeting somatic gene therapy to joints does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Targeting somatic gene therapy to joints, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Targeting somatic gene therapy to joints will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1962124

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.